Maravai Lifesciences Holdings (MRVI) Times Interest Earned (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Times Interest Earned of -$0.35 for Q1 2026, up 81.34% year-over-year from -$0.19 in Q1 2025, and up 95.09% quarter-over-quarter from -$7.15 in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Times Interest Earned (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.35 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 81.34% year-over-year to -$0.35; the TTM figure through Mar 2026 stood at -$4.48 (up 55.99% YoY), while the FY2025 annual figure was -$6.25, down 1738.05% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.35, up from -$7.15 in the prior quarter.
- The five-year high for Times Interest Earned was $12.44 in Q4 2022, with the low at -$7.15 in Q4 2025.
- The 5-year median for Times Interest Earned is -$0.59 (2023), against an average of $0.24.
- The sharpest annual moves came in 2024 and 2026: Times Interest Earned sank 1699.75% in 2024, then surged 81.34% in 2026.
- Maravai Lifesciences Holdings' Times Interest Earned stood at $12.44 in 2022, then slumped by 104.18% to -$0.52 in 2023, then plunged by 544.39% to -$3.35 in 2024, then tumbled by 113.65% to -$7.15 in 2025, then soared by 95.09% to -$0.35 in 2026.
- Business Quant data shows MRVI's Times Interest Earned at -$0.35 in Q1 2026, -$7.15 in Q4 2025, and -$1.56 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | -3.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.14 |
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | -7.15 |
| Sep 30, 2025 | -1.56 |
| Jun 30, 2025 | -2.53 |
| Mar 31, 2025 | -1.88 |
| Dec 31, 2024 | -3.35 |
| Sep 30, 2024 | -6.37 |
| Jun 30, 2024 | -1.13 |
| Mar 31, 2024 | -1.55 |
| Dec 31, 2023 | -0.52 |
| Sep 30, 2023 | -0.59 |
| Jun 30, 2023 | -0.45 |
| Mar 31, 2023 | 0.10 |
| Dec 31, 2022 | 12.44 |
| Sep 30, 2022 | 4.78 |
| Jun 30, 2022 | 7.40 |
| Mar 31, 2022 | 6.85 |
| Dec 31, 2021 | 16.02 |
| Sep 30, 2021 | 10.78 |